Which has the lower trailing P/E, DMII or ROOT?

ROOT has the lower trailing P/E: DMII trades at 34.76 and ROOT at 14.00. P/E is one valuation measure and does not by itself establish which business is cheaper.

Is DMII or ROOT more profitable?

ROOT runs the higher net margin — DMII at 0.00% versus ROOT at 3.90%.

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) vs Root, Inc. (ROOT)

A side-by-side comparison of Drugs Made In America Acquisition II Corp. Ordinary Shares and Root, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DMII

Drugs Made In America Acquisition II Corp. Ordinary Shares

$649M

$10.19Financial ServicesDelayed quote: Oct 6, 2026, 4:00 PM EDT

ROOT

Root, Inc.

$661M

$47.17Financial ServicesDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — DMII vs ROOT

growth of $100 · dividends reinvested · last 1y

DMII +3.1% (+3.1%/yr)ROOT -38.8% (-38.8%/yr)DMII compounded faster over this window

DMII ROOT

DMII vs ROOT: by the numbers

•ROOT is the larger company ($661M vs $649M market cap).
•ROOT trades at the lower trailing earnings multiple (14.00 vs 34.76 P/E), one valuation lens rather than an overall verdict.
•ROOT is profitable (3.90% net margin) while DMII runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	DMII	ROOT
P/E ratio	34.76	14.00
Forward P/E	N/A	10.53
P/S ratio	N/A	0.42
P/B ratio	1.31	2.02

Profitability

Metric	DMII	ROOT
Gross margin	0.00%	N/A
Operating margin	0.00%	3.96%
Net margin	0.00%	3.90%
ROE	2.62%	18.66%
ROIC	-0.28%	N/A

Root, Inc.: Gross margin is not shown for a lender or insurer: its revenue is interest, premiums and fees rather than the sale of goods, so there is no cost of goods sold to measure it against.

Growth (annualized)

Metric	DMII	ROOT
Revenue CAGR (5Y)	N/A	43.26%
Total return CAGR (5Y)	N/A	-11.85%

Frequently asked

Which has the lower trailing P/E, DMII or ROOT?: ROOT has the lower trailing P/E: DMII trades at 34.76 and ROOT at 14.00. P/E is one valuation measure and does not by itself establish which business is cheaper.
Is DMII or ROOT more profitable?: ROOT runs the higher net margin — DMII at 0.00% versus ROOT at 3.90%.

Go deeper

Full DMII analysis Full ROOT analysis Interactive comparison tool

Dig into the metrics

Drugs Made In America Acquisition II Corp. Ordinary Shares P/E ratio Root P/E ratio Drugs Made In America Acquisition II Corp. Ordinary Shares ROE Root ROE Drugs Made In America Acquisition II Corp. Ordinary Shares operating margin Root operating margin Drugs Made In America Acquisition II Corp. Ordinary Shares revenue growth Root revenue growth Drugs Made In America Acquisition II Corp. Ordinary Shares free cash flow

Drugs Made In America Acquisition II Corp. Ordinary Shares & Root appear in these rankings

Fastest Revenue Growth Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.